NYSE · CIK 0000816956
CNMD CONMED Corp
Insider trading from SEC Form 4. Last filing 32 d ago. Close $44.42 on Oct 9, 2026, +38% from the 52-week low and -14% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
22
with a Form 4 at this company
Price and insider trades, last year
CNMDOct 9, 2026 · close 44.42
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at CONMED Corp, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | Richard Glaze Chief Information Officer sell | $11k 257 shares | -100% | +6% from low-44% from high | |
| 33Weak | Todd W Garner Executive Vice President & CFO sell | $151k 3,500 shares | -66% | +4% from low-42% from high | |
| 30Weak | Charles Farkas director sell | $107k 2,000 shares | -12% | +11% from low-31% from high | |
| 47Moderate | Todd W Garner Executive Vice President & CFO sell | $31k 598 shares | -100% | +12% from low-30% from high | |
| 33Weak | Charles Farkas director sell | $228k 4,000 shares | -20% | +20% from low-26% from high | |
| 35Weak | Richard Glaze Chief Information Officer sell | $17k 257 shares | -100% | - |
Transactions
The last 80 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Kim Kelderman director | MOption exercise Common Stock | +500 | $0.00 | $0 | 500 | 32 d ago |
| Sep 8, 2026 | Kim Kelderman director | MOption exercise RSUs (Restricted Stock Units)derivative | -500 | $0.00 | $0 | 0 | 32 d ago |
| Nov 21, 2025 | Richard Glaze Chief Information Officer | SOpen-market sale Common Stock10b5-1 | -257 | $41.21 | $11k | 0 | Nov 24, 2025 |
| Nov 20, 2025 | Richard Glaze Chief Information Officer | MOption exercise Common Stock | +375 | $0.00 | $0 | 375 | Nov 21, 2025 |
| Nov 20, 2025 | Richard Glaze Chief Information Officer | FTax withholding Common Stock | -118 | $40.63 | $4,794 | 257 | Nov 21, 2025 |
| Nov 20, 2025 | Richard Glaze Chief Information Officer | MOption exercise RSUs (Restricted Stock Units)derivative | -375 | $0.00 | $0 | 750 | Nov 21, 2025 |
| Nov 6, 2025 | Todd W Garner Executive Vice President & CFO | SOpen-market sale Common Stock10b5-1 | -3,500 | $43.00 | $151k | 1,836 | Nov 7, 2025 |
| Nov 4, 2025 | Hollie K Foust General Counsel & Corp Sec | MOption exercise Common Stock | +4,000 | $0.00 | $0 | 4,000 | Nov 5, 2025 |
| Nov 4, 2025 | Hollie K Foust General Counsel & Corp Sec | FTax withholding Common Stock | -1,114 | $45.71 | $51k | 2,886 | Nov 5, 2025 |
| Nov 4, 2025 | Hollie K Foust General Counsel & Corp Sec | MOption exercise RSUs (Restricted Stock Units)derivative | -4,000 | $0.00 | $0 | 4,000 | Nov 5, 2025 |
| Oct 31, 2025 | Todd W Garner Executive Vice President & CFO | MOption exercise Common Stock | +7,500 | $0.00 | $0 | 7,500 | Nov 3, 2025 |
| Oct 31, 2025 | Todd W Garner Executive Vice President & CFO | FTax withholding Common Stock | -2,164 | $44.00 | $95k | 5,336 | Nov 3, 2025 |
| Oct 31, 2025 | Todd W Garner Executive Vice President & CFO | MOption exercise RSUs (Restricted Stock Units)derivative | -7,500 | $0.00 | $0 | 15,227 | Nov 3, 2025 |
| Sep 12, 2025 | Charles Farkas director | SOpen-market sale Common Stock | -1,103 | $53.54 | $59k | 15,756 | Sep 15, 2025 |
| Sep 12, 2025 | Charles Farkas director | SOpen-market sale Common Stock | -897 | $53.51 | $48k | 14,859 | Sep 15, 2025 |
| Sep 8, 2025 | Kim Kelderman director | AGrant or award RSUs (Restricted Stock Units)derivative | +500 | $0.00 | $0 | 500 | Sep 9, 2025 |
| Sep 8, 2025 | Kim Kelderman director | AGrant or award Options To Purchase Common Stockderivative | +6,227 | $0.00 | $0 | 6,227 | Sep 9, 2025 |
| Aug 7, 2025 | Todd W Garner Executive Vice President & CFO | SOpen-market sale Common Stock | -598 | $52.45 | $31k | 0 | Aug 8, 2025 |
| Jun 2, 2025 | Mark Kaye director | AGrant or award Options To Purchase Common Stockderivative | +8,061 | $0.00 | $0 | 8,061 | Jun 4, 2025 |
| Jun 3, 2025 | Barbara J Schwarzentraub director | MOption exercise Common Stock | +479 | $0.00 | $0 | 4,344 | Jun 4, 2025 |
| Jun 3, 2025 | Brian Concannon director | MOption exercise Common Stock | +479 | $0.00 | $0 | 10,116 | Jun 4, 2025 |
| Jun 3, 2025 | Charles Farkas director | MOption exercise Common Stock | +479 | $0.00 | $0 | 16,859 | Jun 4, 2025 |
| Jun 3, 2025 | LaVerne H Council director | MOption exercise Common Stock | +479 | $0.00 | $0 | 4,048 | Jun 4, 2025 |
| Jun 3, 2025 | David M. Bronson director | MOption exercise Common Stock | +479 | $0.00 | $0 | 17,241 | Jun 4, 2025 |
| Jun 3, 2025 | Martha Goldberg Aronson director | MOption exercise Common Stock | +479 | $0.00 | $0 | 12,391 | Jun 4, 2025 |
| Jun 2, 2025 | Mark Kaye director | AGrant or award RSUs (Restricted Stock Units)derivative | +668 | $0.00 | $0 | 668 | Jun 4, 2025 |
| Jun 2, 2025 | Brian Concannon director | AGrant or award Options To Purchase Common Stockderivative | +8,061 | $0.00 | $0 | 8,061 | Jun 4, 2025 |
| Jun 2, 2025 | David M. Bronson director | AGrant or award Options To Purchase Common Stockderivative | +8,061 | $0.00 | $0 | 8,061 | Jun 4, 2025 |
| Jun 2, 2025 | LaVerne H Council director | AGrant or award Options To Purchase Common Stockderivative | +8,061 | $0.00 | $0 | 8,061 | Jun 4, 2025 |
| Jun 2, 2025 | Charles Farkas director | AGrant or award Options To Purchase Common Stockderivative | +8,061 | $0.00 | $0 | 8,061 | Jun 4, 2025 |
| Jun 2, 2025 | Barbara J Schwarzentraub director | AGrant or award Options To Purchase Common Stockderivative | +8,061 | $0.00 | $0 | 8,061 | Jun 4, 2025 |
| Jun 2, 2025 | Brian Concannon director | AGrant or award RSUs (Restricted Stock Units)derivative | +668 | $0.00 | $0 | 668 | Jun 4, 2025 |
| Jun 2, 2025 | Martha Goldberg Aronson director | AGrant or award Options To Purchase Common Stockderivative | +8,061 | $0.00 | $0 | 8,061 | Jun 4, 2025 |
| Jun 2, 2025 | David M. Bronson director | AGrant or award RSUs (Restricted Stock Units)derivative | +668 | $0.00 | $0 | 668 | Jun 4, 2025 |
| Jun 2, 2025 | LaVerne H Council director | AGrant or award RSUs (Restricted Stock Units)derivative | +668 | $0.00 | $0 | 668 | Jun 4, 2025 |
| Jun 2, 2025 | Charles Farkas director | AGrant or award RSUs (Restricted Stock Units)derivative | +668 | $0.00 | $0 | 668 | Jun 4, 2025 |
| Jun 3, 2025 | LaVerne H Council director | MOption exercise RSUs (Restricted Stock Units)derivative | -479 | $0.00 | $0 | 0 | Jun 4, 2025 |
| Jun 2, 2025 | Barbara J Schwarzentraub director | AGrant or award RSUs (Restricted Stock Units)derivative | +668 | $0.00 | $0 | 668 | Jun 4, 2025 |
| Jun 2, 2025 | Martha Goldberg Aronson director | AGrant or award RSUs (Restricted Stock Units)derivative | +668 | $0.00 | $0 | 668 | Jun 4, 2025 |
| Jun 3, 2025 | Brian Concannon director | MOption exercise RSUs (Restricted Stock Units)derivative | -479 | $0.00 | $0 | 0 | Jun 4, 2025 |
| Jun 3, 2025 | Charles Farkas director | MOption exercise RSUs (Restricted Stock Units)derivative | -479 | $0.00 | $0 | 0 | Jun 4, 2025 |
| Jun 3, 2025 | David M. Bronson director | MOption exercise RSUs (Restricted Stock Units)derivative | -479 | $0.00 | $0 | 0 | Jun 4, 2025 |
| Jun 3, 2025 | Barbara J Schwarzentraub director | MOption exercise RSUs (Restricted Stock Units)derivative | -479 | $0.00 | $0 | 0 | Jun 4, 2025 |
| Jun 3, 2025 | Martha Goldberg Aronson director | MOption exercise RSUs (Restricted Stock Units)derivative | -479 | $0.00 | $0 | 0 | Jun 4, 2025 |
| May 29, 2025 | Charles Farkas director | MOption exercise Common Stock | +1,000 | $55.70 | $56k | 17,346 | May 30, 2025 |
| May 29, 2025 | Charles Farkas director | FTax withholding Common Stock | -966 | $57.69 | $56k | 16,380 | May 30, 2025 |
| May 29, 2025 | Charles Farkas director | MOption exercise SARs (Stock Appreciation Rights)derivative | -1,000 | $0.00 | $0 | 0 | May 30, 2025 |
| May 20, 2025 | John L Workman director | MOption exercise Common Stock | +479 | $59.84 | $29k | 20,891 | May 21, 2025 |
| May 20, 2025 | John L Workman director | MOption exercise RSUs (Restricted Stock Units)derivative | -479 | $0.00 | $0 | 0 | May 21, 2025 |
| Mar 3, 2025 | Stephan Epinette VP GM International | AGrant or award RSUs (Restricted Stock Units)derivative | +17,144 | $0.00 | $0 | 17,144 | May 15, 2025 |
| May 5, 2025 | Charles Farkas director | SOpen-market sale Common Stock | -4,000 | $56.94 | $228k | 16,346 | May 6, 2025 |
| Apr 28, 2025 | Matthew Schabacker VP GM Advanced Surgical | AGrant or award Options To Purchase Common Stockderivative | +31,675 | $0.00 | $0 | 31,675 | May 1, 2025 |
| Mar 31, 2025 | Todd W Garner Executive Vice President & CFO | AGrant or award Common Stock | +371 | $57.37 | $21k | 598 | Apr 8, 2025 |
| Mar 14, 2025 | Peter K Shagory EVP, STRAT & CORP DEVT | MOption exercise Common Stock | +4,500 | $55.42 | $249k | 8,213 | Mar 17, 2025 |
| Mar 14, 2025 | Peter K Shagory EVP, STRAT & CORP DEVT | FTax withholding Common Stock | -4,316 | $58.83 | $254k | 3,897 | Mar 17, 2025 |
| Mar 14, 2025 | Peter K Shagory EVP, STRAT & CORP DEVT | MOption exercise SARs (Stock Appreciation Rights)derivative | -4,500 | $0.00 | $0 | 0 | Mar 17, 2025 |
| Mar 7, 2025 | Brent Lalomia Vice President QA and RA | MOption exercise Common Stock | +75 | $0.00 | $0 | 1,032 | Mar 11, 2025 |
| Mar 7, 2025 | Brent Lalomia Vice President QA and RA | FTax withholding Common Stock | -26 | $62.74 | $1,631 | 1,006 | Mar 11, 2025 |
| Mar 7, 2025 | Brent Lalomia Vice President QA and RA | MOption exercise RSUs (Restricted Stock Units)derivative | -75 | $0.00 | $0 | 75 | Mar 11, 2025 |
| Mar 3, 2025 | Peter K Shagory EVP, STRAT & CORP DEVT | AGrant or award Options To Purchase Common Stockderivative | +26,127 | $0.00 | $0 | 26,127 | Mar 5, 2025 |
| Mar 3, 2025 | Todd W Garner Executive Vice President & CFO | AGrant or award Options To Purchase Common Stockderivative | +61,475 | $0.00 | $0 | 61,475 | Mar 5, 2025 |
| Mar 3, 2025 | Richard Glaze Chief Information Officer | AGrant or award Options To Purchase Common Stockderivative | +11,750 | $0.00 | $0 | 11,750 | Mar 5, 2025 |
| Mar 3, 2025 | Brent Lalomia Vice President QA and RA | AGrant or award Options To Purchase Common Stockderivative | +26,895 | $0.00 | $0 | 26,895 | Mar 5, 2025 |
| Mar 3, 2025 | Johonna Marie Pelletier Treasurer and VP, Tax | AGrant or award Options To Purchase Common Stockderivative | +9,300 | $0.00 | $0 | 9,300 | Mar 5, 2025 |
| Mar 3, 2025 | John D. Ferrell Executive Vice President - HR | AGrant or award Options To Purchase Common Stockderivative | +21,516 | $0.00 | $0 | 21,516 | Mar 5, 2025 |
| Mar 3, 2025 | Hollie K Foust General Counsel & Corp Sec | AGrant or award Options To Purchase Common Stockderivative | +30,738 | $0.00 | $0 | 30,738 | Mar 5, 2025 |
| Mar 3, 2025 | Edward A. Clifford VP Global Manufacturing | AGrant or award Options To Purchase Common Stockderivative | +26,127 | $0.00 | $0 | 26,127 | Mar 5, 2025 |
| Feb 24, 2025 | Mark Kaye director | AGrant or award Options To Purchase Common Stockderivative | +1,846 | $0.00 | $0 | 1,846 | Feb 26, 2025 |
| Feb 24, 2025 | Mark Kaye director | AGrant or award RSUs (Restricted Stock Units)derivative | +152 | $0.00 | $0 | 152 | Feb 26, 2025 |
| Feb 11, 2025 | Richard Glaze Chief Information Officer | SOpen-market sale Common Stock | -257 | $65.35 | $17k | 0 | Feb 13, 2025 |
| Jan 27, 2025 | Andrew James Moller VP Corporate Controller | AGrant or award Options To Purchase Common Stockderivative | +5,000 | $0.00 | $0 | 5,000 | Jan 30, 2025 |
| Jan 2, 2025 | Pat Beyer President & CEO | AGrant or award Options To Purchase Common Stockderivative | +86,355 | $0.00 | $0 | 86,355 | Jan 6, 2025 |
| Nov 20, 2024 | Richard Glaze Chief Information Officer | MOption exercise Common Stock | +375 | $0.00 | $0 | 375 | Nov 21, 2024 |
| Nov 20, 2024 | Richard Glaze Chief Information Officer | FTax withholding Common Stock | -118 | $70.69 | $8,341 | 257 | Nov 21, 2024 |
| Nov 20, 2024 | Richard Glaze Chief Information Officer | MOption exercise RSUs (Restricted Stock Units)derivative | -375 | $0.00 | $0 | 1,125 | Nov 21, 2024 |
| Nov 7, 2024 | Curt R Hartman President and CEO | MOption exercise Common Stock | +30,000 | $51.30 | $1.5M | 34,299 | Nov 8, 2024 |
| Nov 7, 2024 | Curt R Hartman President and CEO | FTax withholding Common Stock | -24,303 | $74.76 | $1.8M | 9,996 | Nov 8, 2024 |
| Nov 7, 2024 | Curt R Hartman President and CEO | MOption exercise SARs (Stock Appreciation Rights)derivative | -30,000 | $0.00 | $0 | 118,300 | Nov 8, 2024 |
| Nov 4, 2024 | Hollie K Foust General Counsel & Corp Sec | AGrant or award RSUs (Restricted Stock Units)derivative | +8,000 | $0.00 | $0 | 8,000 | Nov 6, 2024 |
| Nov 1, 2024 | Todd W Garner Executive Vice President & CFO | AGrant or award RSUs (Restricted Stock Units)derivative | +22,727 | $0.00 | $0 | 22,727 | Nov 5, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Martha Goldberg Aronsondirector, ceo, president, officer
- Pat BeyerPresident & CEO
- David M. Bronsondirector
- Edward A. CliffordVP Global Manufacturing
- Brian Concannondirector
- LaVerne H Councildirector
- Stephan EpinetteVP GM International
- Charles Farkasdirector
- John D. FerrellExecutive Vice President - HR
- Hollie K FoustGeneral Counsel & Corp Sec
- Todd W GarnerExecutive Vice President & CFO
- Richard GlazeChief Information Officer
- Curt R HartmanPresident and CEO
- Mark Kayedirector, cfo, officer
- Kim Keldermanceo, officer, director
- Brent LalomiaVice President QA and RA
- Andrew James MollerVP Corporate Controller
- Johonna Marie PelletierTreasurer and VP, Tax
- Peter K ShagoryEVP, STRAT & CORP DEVT
- Matthew SchabackerVP GM Advanced Surgical
- Barbara J Schwarzentraubdirector
- John L Workmandirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.